Effects of heavy‐load strength training during (neo‐)adjuvant chemotherapy on muscle strength, muscle fiber size, myonuclei, and satellite cells in women with breast cancer
Authors:
- Olav VikmoenOVOlav Vikmoen
- Emelie StrandbergESEmelie Strandberg
- Anna HenrikssonAHAnna Henriksson
- Anne‐Sophie MazzoniAMAnne‐Sophie Mazzoni
- Birgitta JohanssonBJBirgitta Johansson
- Andreas KarakatsanisAKAndreas Karakatsanis
- Matilda AnnebäckMAMatilda Annebäck
- Henrik LindmanHLHenrik Lindman
- Fredrik WärnbergFWFredrik Wärnberg
- 2 July 2024
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 38 (13) , e23784
Abstract
To investigate the effects of heavy‐load strength training during (neo‐)adjuvant chemotherapy in women with breast cancer on muscle strength, body composition, muscle fiber size, satellite cells, and myonuclei. Women with stage I‐III breast cancer were randomly assigned to a strength training group (ST, n = 23) performing supervised heavy‐load strength training twice a week during chemotherapy, or a usual care control group (CON, n = 17). Muscle strength and body composition were measured and biopsies from m. vastus lateralis collected before the first cycle of chemotherapy (T0) and after chemotherapy and training (T1). Muscle strength increased significantly more in ST than in CON in chest‐press (ST: +10 ± 8%, p < .001, CON: −3 ± 5%, p = .023) and leg‐press (ST: +11 ± 8%, p < .001, CON: +3 ± 6%, p = .137). Both groups reduced fat‐free mass (ST: −4.9 ± 4.0%, p < .001, CON: −5.2 ± 4.9%, p = .004), and increased fat mass (ST: +15.3 ± 16.5%, p < .001, CON: +16.3 ± 19.8%, p = .015) with no significant differences between groups. No significant changes from T0 to T1 and no significant differences between groups were observed in muscle fiber size. For myonuclei per fiber a non‐statistically significant increase in CON and a non‐statistically significant decrease in ST in type I fibers tended ( p = .053) to be different between groups. Satellite cells tended to decrease in ST (type I: −14 ± 36%, p = .097, type II: −9 ± 55%, p = .084), with no changes in CON and no differences between groups. Strength training during chemotherapy improved muscle strength but did not significantly affect body composition, muscle fiber size, numbers of satellite cells, and myonuclei compared to usual care.Keywords
Funding Information
- Cancerfonden (18 0356)
- Kreftforeningen (198149)
This publication has 50 references indexed in Scilit:
- Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancerCancer, 2022
- Body composition and breast cancer risk and treatment: mechanisms and impactBreast Cancer Research and Treatment, 2021
- Distinct trajectories of moderate to vigorous physical activity and sedentary behavior following a breast cancer diagnosis: the Pathways StudyJournal of Cancer Survivorship, 2020
- Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic reviewBreast Cancer Research and Treatment, 2019
- Molecular and cellular adaptations to exercise training in skeletal muscle from cancer patients treated with chemotherapyJournal of Cancer Research and Clinical Oncology, 2019
- Highly favorable physiological responses to concurrent resistance and high-intensity interval training during chemotherapy: the OptiTrain breast cancer trialBreast Cancer Research and Treatment, 2018
- Skeletal muscle fiber size and fiber type distribution in human cancer: Effects of weight loss and relationship to physical functionClinical Nutrition, 2016
- Exercise for women receiving adjuvant therapy for breast cancerCochrane Database of Systematic Reviews, 2016
- Tissue retention of doxorubicin and its effects on cardiac, smooth, and skeletal muscle functionJournal of Physiology and Biochemistry, 2012
- The impact of sarcopenia and exercise training on skeletal muscle satellite cellsAgeing Research Reviews, 2009